107 related articles for article (PubMed ID: 10618534)
1. A prime-boost immunization strategy with DNA and recombinant baculovirus-expressed protein enhances protective immunogenicity of glycoprotein D of equine herpesvirus 1 in naïve and infection-primed mice.
Ruitenberg KM; Walker C; Love DN; Wellington JE; Whalley JM
Vaccine; 2000 Jan; 18(14):1367-73. PubMed ID: 10618534
[TBL] [Abstract][Full Text] [Related]
2. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474
[TBL] [Abstract][Full Text] [Related]
3. Equine herpesvirus 1 glycoprotein D expressed in E. coli provides partial protection against equine herpesvirus infection in mice and elicits virus-neutralizing antibodies in the horse.
Weerasinghe CU; Learmonth GS; Gilkerson JR; Foote CE; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2006 May; 111(1-2):59-66. PubMed ID: 16473414
[TBL] [Abstract][Full Text] [Related]
4. DNA-mediated immunization with glycoprotein D of equine herpesvirus 1 (EHV-1) in a murine model of EHV-1 respiratory infection.
Ruitenberg KM; Walker C; Wellington JE; Love DN; Whalley JM
Vaccine; 1999 Jan; 17(3):237-44. PubMed ID: 9987159
[TBL] [Abstract][Full Text] [Related]
5. Equine herpesvirus 1 glycoprotein D expressed in Pichia pastoris is hyperglycosylated and elicits a protective immune response in the mouse model of EHV-1 disease.
Ruitenberg KM; Gilkerson JR; Wellington JE; Love DN; Whalley JM
Virus Res; 2001 Nov; 79(1-2):125-35. PubMed ID: 11551653
[TBL] [Abstract][Full Text] [Related]
6. Inoculation with DNA encoding the glycoprotein gp2 reduces severity of equine herpesvirus 1 infection in a mouse respiratory model.
Learmonth GS; Love DN; Gilkerson JR; Wellington JE; Whalley JM
Arch Virol; 2003 Sep; 148(9):1805-13. PubMed ID: 14505091
[TBL] [Abstract][Full Text] [Related]
7. Intramuscular Immunization of Mice with the Live-Attenuated Herpes Simplex Virus 1 Vaccine Strain VC2 Expressing Equine Herpesvirus 1 (EHV-1) Glycoprotein D Generates Anti-EHV-1 Immune Responses in Mice.
Liu SA; Stanfield BA; Chouljenko VN; Naidu S; Langohr I; Del Piero F; Ferracone J; Roy AA; Kousoulas KG
J Virol; 2017 Jun; 91(12):. PubMed ID: 28404844
[TBL] [Abstract][Full Text] [Related]
8. Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB).
Osterrieder N; Wagner R; Brandmüller C; Schmidt P; Wolf H; Kaaden OR
Virology; 1995 Apr; 208(2):500-10. PubMed ID: 7747423
[TBL] [Abstract][Full Text] [Related]
9. Equine herpesvirus 1 (EHV-1) glycoprotein D DNA inoculation in horses with pre-existing EHV-1/EHV-4 antibody.
Ruitenberg KM; Love DN; Gilkerson JR; Wellington JE; Whalley JM
Vet Microbiol; 2000 Sep; 76(2):117-27. PubMed ID: 10946142
[TBL] [Abstract][Full Text] [Related]
10. Characterization of immune responses to baculovirus-expressed equine herpesvirus type 1 glycoproteins D and H in a murine model.
Tewari D; Whalley JM; Love DN; Field HJ
J Gen Virol; 1994 Jul; 75 ( Pt 7)():1735-41. PubMed ID: 8021602
[TBL] [Abstract][Full Text] [Related]
11. Potential of DNA-mediated vaccination for equine herpesvirus 1.
Ruitenberg KM; Walker C; Wellington JE; Love DN; Whalley JM
Vet Microbiol; 1999 Aug; 68(1-2):35-48. PubMed ID: 10501160
[TBL] [Abstract][Full Text] [Related]
12. TLR-5 agonist Salmonella abortus equi flagellin FliC enhances FliC-gD-based DNA vaccination against equine herpesvirus 1 infection.
Zhao Y; Chang J; Zhang B; Tong P; Wang C; Ran D; Su Y
Arch Virol; 2019 May; 164(5):1371-1382. PubMed ID: 30888564
[TBL] [Abstract][Full Text] [Related]
13. Immune responses and protective efficacy of recombinant baculovirus-expressed glycoproteins of equine herpesvirus 1 (EHV-1) gB, gC and gD alone or in combinations in BALB/c mice.
Packiarajah P; Walker C; Gilkerson J; Whalley JM; Love DN
Vet Microbiol; 1998 Apr; 61(4):261-78. PubMed ID: 9646476
[TBL] [Abstract][Full Text] [Related]
14. Inoculation of mares and very young foals with EHV-1 glycoproteins D and B reduces virus shedding following respiratory challenge with EHV-1.
Foote CE; Raidal SL; Pecenpetelovska G; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2006 May; 111(1-2):97-108. PubMed ID: 16504306
[TBL] [Abstract][Full Text] [Related]
15. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.
Soboll G; Hussey SB; Whalley JM; Allen GP; Koen MT; Santucci N; Fraser DG; Macklin MD; Swain WF; Lunn DP
Vet Immunol Immunopathol; 2006 May; 111(1-2):81-95. PubMed ID: 16549215
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of equine herpesvirus-1 (EHV-1) glycoprotein B in a murine model of EHV-1-induced abortion.
Kukreja A; Walker C; Fitzmaurice T; Awan A; Love DN; Whalley JM; Field HJ
Vet Microbiol; 1998 Aug; 62(4):303-11. PubMed ID: 9791876
[TBL] [Abstract][Full Text] [Related]
17. EHV-1 glycoprotein D (EHV-1 gD) is required for virus entry and cell-cell fusion, and an EHV-1 gD deletion mutant induces a protective immune response in mice.
Csellner H; Walker C; Wellington JE; McLure LE; Love DN; Whalley JM
Arch Virol; 2000; 145(11):2371-85. PubMed ID: 11205124
[TBL] [Abstract][Full Text] [Related]
18. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
Minke JM; Fischer L; Baudu P; Guigal PM; Sindle T; Mumford JA; Audonnet JC
Vet Immunol Immunopathol; 2006 May; 111(1-2):47-57. PubMed ID: 16580075
[TBL] [Abstract][Full Text] [Related]
19. Immunization with glycoprotein C of equine herpesvirus-1 is associated with accelerated virus clearance in a murine model.
Tewari D; Nair SV; De Ungria MC; Lawrence GL; Hayden M; Love DN; Field HJ; Whalley JM
Arch Virol; 1995; 140(4):789-97. PubMed ID: 7794119
[TBL] [Abstract][Full Text] [Related]
20. High level expression of equine herpesvirus 1 glycoproteins D and H and their role in protection against virus challenge in the C3H (H-2Kk) murine model.
Stokes A; Cameron RS; Marshall RN; Killington RA
Virus Res; 1997 Aug; 50(2):159-73. PubMed ID: 9282781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
